UBS Group
EXEL icon

UBS Group’s Exelixis EXEL Stock Holding History

UBS Group’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,700
Closed -$233K – 9492
2023
Q4 		$233K Hold
9,700
– – ﹤0.01% 5690
2023
Q3 		$212K Hold
9,700
– – ﹤0.01% 5327
2023
Q2 		$185K Hold
9,700
– – ﹤0.01% 5535
2023
Q1 		$188K Buy
+9,700
New +$169K ﹤0.01% 5422
2017
Q2 		– Sell
-1,400,000
Closed -$30.3M – 7755
2017
Q1 		$30.3M Buy
1,400,000
+900,000
+180% +$18.3M 0.02% 780
2016
Q4 		$7.46M Buy
+500,000
New +$7.21M ﹤0.01% 1744
2015
Q1 		– Sell
-800
Closed -$1K – 8970
2014
Q4 		$1K Buy
+800
New +$1.25K ﹤0.01% 9533

Other funds holding EXEL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

UBS Group's EXEL Position: Q3 2026 in Review

UBS Group reduced its Exelixis (EXEL) stake by 52% in Q3 2026, selling an estimated $91.8M and leaving 1,521,074 shares worth $88.8M. The position accounts for 0.01% of the portfolio, ranked #1185.

UBS Group first reported a position in EXEL in Q4 2014 and has held it in 48 quarters since. The position peaked at $172M in Q2 2026. 637 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • UBS Group held 1,521,074 shares of Exelixis worth $88.8M as of Q3 2026.
  • UBS Group sold 1,646,816 Exelixis shares in Q3 2026, an estimated $91.8M.
  • Exelixis made up 0.01% of UBS Group's portfolio in Q3 2026, its #1185 holding.
  • UBS Group first reported a position in Exelixis in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Exelixis position peaked at $172M in Q2 2026.
  • 637 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.